Publicaciones en las que colabora con Elena Puerta Ruiz de Azua (12)

2024

  1. Neuropathological stage-dependent proteome mapping of the olfactory tract in Alzheimer's disease: From early olfactory-related omics signatures to computational repurposing of drug candidates

    Brain Pathology, Vol. 34, Núm. 4

2023

  1. SIRT2 Inhibition Rescues Neurodegenerative Pathology but Increases Systemic Inflammation in a Transgenic Mouse Model of Alzheimer’s Disease

    Journal of Neuroimmune Pharmacology, Vol. 18, Núm. 3, pp. 529-550

2022

  1. Trimethylamine N-oxide (TMAO) drives insulin resistance and cognitive deficiencies in a senescence accelerated mouse model

    Mechanisms of Ageing and Development, Vol. 204

2021

  1. Biomarcadores en la enfermedad de Alzheimer

    Advances in Laboratory Medicine, Vol. 2, Núm. 1, pp. 39-50

  2. Biomarkers in Alzheimer's disease

    Advances in Laboratory Medicine, Vol. 2, Núm. 1, pp. 27-37

2020

  1. THE SAMP8 MOUSE AS A MODEL OF ACCELERATED SENESCENCE

    Encyclopedia of Cell Biology: New Research (9 Volume Set) (Nova Science Publishers, Inc.), pp. 1465-1492

2018

  1. The SAMP8 mouse as a model of accelerated senescence

    New Research on Cell Aging and Death (Nova Science Publishers, Inc.), pp. 1-42

2017

  1. Stress animal models for the study of neuropsychiatric and neurodegenerative disorders

    Horizons in Neuroscience Research (Nova Science Publishers, Inc.), pp. 51-101

2016

  1. Spatial memory assessment: Experimental behavioral tasks in rodents

    Spatial, Long-and Short-Term Memory: Functions, Differences and Effects of Injury (Nova Science Publishers, Inc.), pp. 1-30

2015

  1. Treatment options in Alzheimer´s disease: The GABA story

    Current Pharmaceutical Design, Vol. 21, Núm. 34, pp. 4960-4971

  2. Venlafaxine reverses decreased proliferation in the subventricular zone in a rat model of early life stress

    Behavioural Brain Research, Vol. 292, pp. 79-82

2014

  1. Glutamate and GABA: partners in crime in stress-induced cognitive dysfunction

    Cognitive dysfunctions: biological basis, management of symptoms and long-term neurological implications (NOVA Publishers), pp. 63-86